All news
//
Updates

Translucence and Zeiss Team Up to Expand Possibilities for 3D Tissue Imaging

by
Translucence Biosystems
March 24, 2021

We are excited to announce that Translucence Biosystems has entered into a collaborative and strategic relationship with Carl Zeiss AG to promote the use of the Mesoscale Imaging SystemTM with the new ZEISS Lightsheet 7 microscope, designed to advance the 3D histology revolution.

Learn more about the Zeiss Lightsheet microscopes here.

‍

Download materials

Download materials

To access materials from this article, please complete the corresponding form

Get materials

Mesoscale Imaging System™
Manual

Thank you, for trusting Translucence Biosystems as a partner in your research journey!
No items found.
Something went wrong while submitting the form.
Please, contact us info@translucencebio.com

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

August 13, 2025
Updates

AAIC25 Highlights: Translucence Biosystems Showcases Tools for 3D Whole-Brain Quantification of Alzheimer’s Pathology and Therapeutic Distribution

Translucence Biosystems recently participated in the Alzheimer's Association International Conference® (AAIC25), where CEO Damian Wheeler presented two posters demonstrating Translucence's whole-brain 3D tissue clearing techniques and AI-powered quantification pipeline. These presentations highlighted next-generation methodologies for quantifying disease burden and mapping therapeutic biodistribution at cellular resolution across the entire brain.
by
Angela Prvulovic
Learn More
Learn More
May 12, 2025
Updates

Translucence Biosystems hosts Lunch and Learn Event in Partnership with the UC Berkeley Molecular Imaging Core

Translucence Biosystems hosted an informative Lunch and Learn event in collaboration with the Molecular Imaging Center at the UC Berkeley Cancer Research Lab on Wednesday, April 9th, 2025.
by
Angela Prvulovic
Learn More
Learn More
February 25, 2025
Updates

CEO Damian Wheeler Presents on Brain-Wide Parenchymal Quantification of BBB-Crossing Antibody Therapeutics at Keystone Symposia 2025

Translucence Biosystems CEO Damian Wheeler, presented at the Drug Delivery to the Brain: Emerging Modalities Keystone Symposia meeting held on February 17–20, 2025.
by
Angela Prvulovic
Learn More
Learn More